| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
frédéric leprêtre
|
|||||||
| GSE250145 |
Comparison of transcriptomic profile of the murine B16F1-GFP-M melanoma cells with the derived dormant B16F1-GFP-D, B16F1-GFP-DB#1, B16F1-GFP-DB#2, B16F1-GFP-DB#3 melanoma cells
|
24 | frédéric leprêtre | Sep 13, 2024 | ||||
| GSE250172 |
Myeloid leukemia and melanoma genomic characterization in murine cell lines
|
28 | frédéric leprêtre | Sep 13, 2024 | ||||
| GSE180769 |
Human lung cancer cell line A549 +/- CD43 knockdown
|
4 | frédéric leprêtre | Jul 01, 2024 | ||||
| GSE240778 |
Transciptomic signature of chronic antibody-mediated kidney rejection traited by extracorporeal photopheresis
|
16 | frédéric leprêtre | Feb 28, 2024 | ||||
| GSE184514 |
Trancriptome profiling of genome-edited 16HBE cells on the receptor tyrosine kinase MET in response to HGF
|
16 | frédéric leprêtre | Nov 16, 2023 | ||||
| GSE245725 |
Double ratio of microRNA signatures as promising diagnosis biomarkers for mucinous borderline and malignant ovarian tumors
|
6 | frédéric leprêtre | Oct 19, 2023 | ||||
| GSE237277 |
Comparative analysis of response to treatments and molecular features of tumor- derived organoids versus cell lines and PDX derived from the same clear cell ovarian adenocarcinoma
|
7 | frédéric leprêtre | Jul 18, 2023 | ||||
| GSE228059 |
The Adult T-Cell Leukemia/Lymphoma Cell Line KK1 +/- RhoH Reconstitution
|
4 | frédéric leprêtre | Mar 23, 2023 | ||||
| GSE137130 |
MiRnome profiling of Human bladder cancer line invalidated for the MUC4 gene by ShRNA.
|
16 | frédéric leprêtre | Aug 29, 2022 | ||||
| GSE98437 |
Trancriptome profiling of murine overexpression of p65/RelA mutants
|
24 | frédéric leprêtre | Jul 27, 2022 | ||||
| GSE135136 |
Transcriptome profiling of murine overexpression of p65/RelA mutants II
|
20 | frédéric leprêtre | Jul 27, 2022 | ||||
| GSE135137 |
Transcriptome profiling of murine overexpression of p65/RelA mutants III
|
17 | frédéric leprêtre | Jul 27, 2022 | ||||
| GSE191223 |
Design of a gene signature to analyze the proinflammatory and the profibrotic polarization of murine fibroblasts and validation in an experimental murine model of scleroderma.
|
15 | frédéric leprêtre | Jul 20, 2022 | ||||
| GSE178299 |
IgG from systemic sclerosis patients induce a profibrosing and serotype-dependent phenotype in normal dermal fibroblast: a multi-omics study
|
20 | frédéric leprêtre | Jun 07, 2022 | ||||
| GSE118860 |
Trancriptome profiling of murine lung after pneumococcal respiratory infection, antibiotic administation, and treatment with immunostimulants
|
24 | frédéric leprêtre | Jul 29, 2021 | ||||
| GSE173757 |
Triple-negative breast cancer cell line MDA-MB-231 +/- CD43 knockdown
|
4 | frédéric leprêtre | May 04, 2021 | ||||
| GSE153087 |
Trancriptome profiling of OAW42-R human ovarian carcinoma cell line after transfection with siRNAs directed against UCA1
|
8 | frédéric leprêtre | Apr 21, 2021 | ||||
| GSE111109 |
Trancriptome profiling of murine Hoxa9-transformed MigA9 cell line treated or not with DB818
|
3 | frédéric leprêtre | Feb 01, 2021 | ||||
| GSE156483 |
Hairy Cell Leukemia Cell Line JOK1 +/- RhoH Reconstitution
|
4 | frédéric leprêtre | Jan 03, 2021 | ||||
| GSE162538 |
RNA differential expression between OAW42 ovarian cancer cells and its chemoresistant counterpart OAW42-R
|
2 | frédéric leprêtre | Dec 03, 2020 |
